EU
Emory University Portfolio holdings
AUM
$27.7M
This Quarter Return
+5.99%
1 Year Return
+31.53%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$142M
AUM Growth
+$142M
(-0.15%)
Cap. Flow
+$4.05M
Cap. Flow
% of AUM
2.85%
Top 10 Holdings %
Top 10 Hldgs %
51.56%
Holding
51
New
6
Increased
20
Reduced
15
Closed
5
Top Buys
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$4.01M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$3.16M |
| 3 |
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
|
$2.61M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$2.6M |
| 5 |
MeiraGTx Holdings
MGTX
|
$2.57M |
Top Sells
| 1 |
Solid Biosciences
SLDB
|
$2.75M |
| 2 |
Iovance Biotherapeutics
IOVA
|
$2.45M |
| 3 |
argenx
ARGX
|
$2.35M |
| 4 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
$2.31M |
| 5 |
Crinetics Pharmaceuticals
CRNX
|
$2.21M |
Sector Composition
| 1 | Healthcare | 50.39% |
| 2 | Financials | 32.94% |
| 3 | Consumer Discretionary | 8.74% |
| 4 | Industrials | 2.71% |
| 5 | Real Estate | 1.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ascendis Pharma
ASND
$12B
| $2.11M | 1.49% |
18,334
-14,143
| -44% | -$1.63M |
|
|
GBT
27
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.07M | 1.46% |
39,349
-6,422
| -14% | -$338K |
|
|
THOR
28
DELISTED
Synthorx, Inc. Common Stock
THOR
| $2.04M | 1.44% |
151,048
+31,313
| +26% | +$423K |
|
29
Citigroup
C
$173B
| $2.03M | 1.43% |
28,938
-1,089
| -4% | -$76.3K |
|
30
CBRE Group
CBRE
$47.5B
| $2M | 1.41% |
39,052
+486
| +1% | +$24.9K |
|
31
Seagate
STX
$35.8B
| $1.99M | 1.4% |
42,275
+56
| +0.1% | +$2.64K |
|
32
Bausch Health
BHC
$2.79B
| $1.97M | 1.39% |
78,121
+2,293
| +3% | +$57.8K |
|
33
Arcosa
ACA
$4.75B
| $1.97M | 1.38% |
52,264
-9,078
| -15% | -$342K |
|
34
KKR & Co
KKR
$122B
| $1.94M | 1.37% |
76,943
-5,098
| -6% | -$129K |
|
35
Morgan Stanley
MS
$236B
| $1.9M | 1.34% |
43,300
-2,664
| -6% | -$117K |
|
36
Rhythm Pharmaceuticals
RYTM
$6.97B
| $1.9M | 1.34% |
86,208
+6,810
| +9% | +$150K |
|
37
Trinity Industries
TRN
$2.29B
| $1.88M | 1.32% |
90,599
+14,830
| +20% | +$308K |
|
38
SLM Corp
SLM
$6.38B
| $1.86M | 1.31% |
190,827
+20,798
| +12% | +$202K |
|
39
Bread Financial
BFH
$3.04B
| $1.83M | 1.29% |
13,028
+1,886
| +17% | +$264K |
|
|
ORTX
40
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $1.73M | 1.21% |
123,400
-33,001
| -21% | -$462K |
|
|
MYOV
41
DELISTED
Myovant Sciences Ltd.
MYOV
| $1.61M | 1.13% |
177,988
+66,063
| +59% | +$598K |
|
|
SMC
42
Summit Midstream Corporation
SMC
$284M
| $651K | 0.46% |
87,560
| – | – |
|
43
Home Depot
HD
$406B
| $378K | 0.27% |
+1,819
| New | +$378K |
|
44
Cocrystal Pharma
COCP
$15.8M
| $359K | 0.25% |
152,916
| – | – |
|
45
SPDR S&P 500 ETF Trust
SPY
$652B
| $276K | 0.19% |
942
| – | – |
|
46
InflaRx
IFRX
$117M
| $185K | 0.13% |
58,449
-13,435
| -19% | -$42.5K |
|
|
47
argenx
ARGX
$43.4B
| – | – |
-18,819
| Closed | -$2.35M |
|
|
48
Crinetics Pharmaceuticals
CRNX
$3.01B
| – | – |
-97,035
| Closed | -$2.21M |
|
|
49
Solid Biosciences
SLDB
$438M
| – | – |
-298,887
| Closed | -$2.75M |
|
|
ATNX
50
DELISTED
Athenex, Inc. Common Stock
ATNX
| – | – |
-188,696
| Closed | -$2.31M |
|